GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » Notes Receivable

HeraMED (ASX:HMD) Notes Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is HeraMED Notes Receivable?

HeraMED's Notes Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


HeraMED Notes Receivable Historical Data

The historical data trend for HeraMED's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Notes Receivable Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

HeraMED Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


HeraMED Notes Receivable Related Terms

Thank you for viewing the detailed overview of HeraMED's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


HeraMED (ASX:HMD) Business Description

Traded in Other Exchanges
Address
4 Hazoran Street, POB 8576, Netanya, Netanya, ISR, 4250604
HeraMED Ltd is engaged in developing innovative, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heart beat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR).

HeraMED (ASX:HMD) Headlines

No Headlines